M Alamar1, S Candela2, A Flor-Goikoetxea3, H Salvador4, A F Martinez-Monseny5, J Muchart6, J Hinojosa2. 1. Neurosurgery Department, Hospital Sant Joan de Déu, Passeig de Sant Joan de Déu s/n, 08950, Esplugues de Llobregat, Barcelona, Spain. malamar@sjdhospitalbarcelona.org. 2. Neurosurgery Department, Hospital Sant Joan de Déu, Passeig de Sant Joan de Déu s/n, 08950, Esplugues de Llobregat, Barcelona, Spain. 3. Neurosurgery Department, Hospital de La Ribera, Alzira, Spain. 4. Oncology Department, Hospital Sant Joan de Déu, Barcelona, Spain. 5. Clinical Genetics Department and Pediatric Institute of Rare Diseases (IPER), Hospital Sant Joan de Déu, Barcelona, Spain. 6. Radiology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
Abstract
PURPOSE: We describe our series of 4 patients with megalencephaly-capillary malformation syndrome (MCAP) and review the literature in order to assess the optimal treatment for the associated hydrocephalus. METHODS: We review our institutional series of hydrocephalus associated with MCAP and review the literature, analyzing the causes that could originate the hydrocephalus and the different types of treatments proposed for them. RESULTS: Of our patients treated with ventriculoperitoneal (VP) shunt, one suffered a surgical revision of the shunt and died due to a cranial trauma unrelated to her syndrome or the previous shunt surgery, and the other did not undergo surgical revisions until the end of her follow-up. Our patients treated with endoscopic third ventriculostomy (ETV) have improved their symptomatology and have not suffered of any complications related to the hydrocephalus after the ETV surgery. CONCLUSIONS: We update the treatment of MCAP-associated hydrocephalus and propose ETV as a valid treatment, as it seems a safe procedure with a low rate of complications.
PURPOSE: We describe our series of 4 patients with megalencephaly-capillary malformation syndrome (MCAP) and review the literature in order to assess the optimal treatment for the associated hydrocephalus. METHODS: We review our institutional series of hydrocephalus associated with MCAP and review the literature, analyzing the causes that could originate the hydrocephalus and the different types of treatments proposed for them. RESULTS: Of our patients treated with ventriculoperitoneal (VP) shunt, one suffered a surgical revision of the shunt and died due to a cranial trauma unrelated to her syndrome or the previous shunt surgery, and the other did not undergo surgical revisions until the end of her follow-up. Our patients treated with endoscopic third ventriculostomy (ETV) have improved their symptomatology and have not suffered of any complications related to the hydrocephalus after the ETV surgery. CONCLUSIONS: We update the treatment of MCAP-associated hydrocephalus and propose ETV as a valid treatment, as it seems a safe procedure with a low rate of complications.
Authors: Víctor Martínez-Glez; Valeria Romanelli; María A Mori; Ricardo Gracia; Mabel Segovia; Antonio González-Meneses; Juan C López-Gutierrez; Esther Gean; Loreto Martorell; Pablo Lapunzina Journal: Am J Med Genet A Date: 2010-12 Impact factor: 2.802
Authors: Kim M Keppler-Noreuil; Jonathan J Rios; Victoria E R Parker; Robert K Semple; Marjorie J Lindhurst; Julie C Sapp; Ahmad Alomari; Marybeth Ezaki; William Dobyns; Leslie G Biesecker Journal: Am J Med Genet A Date: 2014-12-31 Impact factor: 2.802
Authors: J Clayton-Smith; B Kerr; H Brunner; L Tranebjaerg; A Magee; R C Hennekam; R F Mueller; L Brueton; M Super; J Steen-Johnsen; D Donnai Journal: Clin Dysmorphol Date: 1997-10 Impact factor: 0.816
Authors: Ghayda M Mirzaa; Robert L Conway; Karen W Gripp; Tally Lerman-Sagie; Dawn H Siegel; Linda S deVries; Dorit Lev; Nancy Kramer; Elizabeth Hopkins; John M Graham; William B Dobyns Journal: Am J Med Genet A Date: 2012-01-06 Impact factor: 2.802
Authors: Karen W Gripp; Elizabeth Hopkins; Chana Vinkler; Dorit Lev; Gustavo Malinger; Tally Lerman-Sagie; William B Dobyns Journal: Am J Med Genet A Date: 2009-05 Impact factor: 2.802
Authors: Pablo Lapunzina; Alba Gairí; Alicia Delicado; M Angeles Mori; M Luisa de Torres; Anton Goma; Marcelo Navia; Isidora López Pajares Journal: Am J Med Genet A Date: 2004-09-15 Impact factor: 2.802